We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
National guidance, information and processes for the NHS fetal anomaly screening programme (FASP).
Guidance on the training of new cervical sample takers.
Guidance on using non-investigational medicinal products in a clinical trial.
Complete a GMS1 form to register with a GP near your home. Bring proof that you are eligible for free healthcare.
Guidance for Applicants wishing to apply for a Promising Innovative Medicines designation, pre-submission meeting or an EAMS Scientific Opinion.
The characteristics, diagnosis and epidemiology of infections caused by spirochaetes of the genus Leptospira (Leptospires).
Yellow fever immunisation information for public health professionals.
Latest developments in vaccines, vaccination policies and procedures for immunisation practitioners.
How to register on the MHRA portal and use it to apply for and update marketing authorisations and make other applications.
How to interpret post-market surveillance (PMS) requirements for medical devices in Great Britain.
How to get state healthcare when you’re on holiday or travelling to Ireland.
Guidance for local NHS screening services on how to order printed population screening leaflets.
Guidance for health and social care professionals on using the ASSIST-Lite tool to identify substance use and provide appropriate intervention.
Guidance on how to manage influenza (flu) using anti-viral agents.
How to respond to individuals at risk of developing pressure ulcers, prevent harm where they occur and raise a safeguarding concern.
Guidance to help public health professionals manage hepatitis A infections and recommendations for pre-exposure immunisation.
Fees payable to the MHRA from 2025.
The characteristics, symptoms, diagnosis and epidemiology of chikungunya.
Guidance for health institutions that manufacture general medical devices under the Health Institution Exemption (HIE).
Information for public health professionals about how vaccines work.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).